These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 24561011)
21. Catheter-based renal denervation: Back on track? Lauder L; Ewen S; Böhm M; Mahfoud F Eur Heart J; 2018 Dec; 39(46):4058-4059. PubMed ID: 30535015 [No Abstract] [Full Text] [Related]
22. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence. Hiremath S; Froeschl M; Ruzicka M Curr Opin Cardiol; 2014 Jul; 29(4):336-43. PubMed ID: 24859619 [TBL] [Abstract][Full Text] [Related]
23. Renal denervation for uncontrolled hypertension: critical review of the evidence. Chen C; Upadhyay A Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):114-122. PubMed ID: 27922849 [TBL] [Abstract][Full Text] [Related]
24. Catheter-based renal denervation: the next chapter begins. Mahfoud F; Schlaich M; Böhm M; Esler M; Lüscher TF Eur Heart J; 2018 Dec; 39(47):4144-4149. PubMed ID: 30239686 [No Abstract] [Full Text] [Related]
25. Renal sympathetic denervation using an externally irrigated radiofrequency ablation catheter for treatment of resistant hypertension - Acute safety and short term efficacy. Yalagudri S; Raju N; Das B; Daware A; Maiya S; Jothiraj K; Ravikishore AG Indian Heart J; 2015; 67(3):207-13. PubMed ID: 26138176 [TBL] [Abstract][Full Text] [Related]
27. Renal denervation for resistant hypertension: not dead yet. Reddy VY; Olin JW J Am Coll Cardiol; 2014 Sep; 64(11):1088-91. PubMed ID: 25212641 [No Abstract] [Full Text] [Related]
28. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension. Ahmed H; Neuzil P; Skoda J; Petru J; Sediva L; Schejbalova M; Reddy VY JACC Cardiovasc Interv; 2012 Jul; 5(7):758-65. PubMed ID: 22814781 [TBL] [Abstract][Full Text] [Related]
29. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension. Hering D; Marusic P; Walton AS; Duval J; Lee R; Sata Y; Krum H; Lambert E; Peter K; Head G; Lambert G; Esler MD; Schlaich MP Int J Cardiol; 2016 Jan; 202():388-93. PubMed ID: 26432488 [TBL] [Abstract][Full Text] [Related]
30. Ambulatory blood pressure may be designed as the primary efficacy outcome in clinical trials on renal denervation. Wang Y Int J Cardiol; 2014 Oct; 176(3):1262-3. PubMed ID: 25115259 [No Abstract] [Full Text] [Related]
31. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension. Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827 [TBL] [Abstract][Full Text] [Related]
32. First report of transradial renal denervation with the dedicated radiofrequency Iberis™ catheter. Honton B; Pathak A; Sauguet A; Fajadet J EuroIntervention; 2014; 9(12):1385-8. PubMed ID: 24161437 [TBL] [Abstract][Full Text] [Related]
35. Acute Vasodilation Caused by Different Strategies of Renal Sympathetic Denervation for Right and Left Renal Arteries. Kiuchi MG; Chen S; Hoye NA Ann Vasc Surg; 2017 Jan; 38():345-347. PubMed ID: 27666799 [No Abstract] [Full Text] [Related]